FAIR VALUE MEASUREMENTS - Subsequent Measurement (Details) |
3 Months Ended |
|---|---|
|
Mar. 31, 2021
USD ($)
| |
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
| Fair value as of January 1, 2021 | $ 24,945,850 |
| Change in valuation inputs or other assumptions | (7,144,117) |
| Fair value as of March 31, 2021 | 17,801,733 |
| Private Placement Warrants | |
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
| Fair value as of January 1, 2021 | 9,663,101 |
| Change in valuation inputs or other assumptions | (2,767,367) |
| Fair value as of March 31, 2021 | 6,895,734 |
| Public Warrants | |
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
| Fair value as of January 1, 2021 | 15,282,750 |
| Change in valuation inputs or other assumptions | (4,376,750) |
| Fair value as of March 31, 2021 | $ 10,906,000 |
| X | ||||||||||
- Definition Represents the amount of increase in warrants liabilities by change in valuation inputs or other assumptions. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|